Evolent Health, Inc. (EVH)

Market Cap	554.22M -1.5%
Revenue (ttm)	2.34B +14.1%
Net Income	-507.69M
EPS	-4.52
Shares Out	113.11M
PE Ratio	n/a
Forward PE	11.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,334,052
Open	4.740
Previous Close	4.770
Day's Range	4.630 - 4.900
52-Week Range	2.095 - 6.255
Beta	1.02
Analysts	Buy
Price Target	5.92 (+20.76%)
Earnings Date	Nov 5, 2026

About EVH

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,200
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$579.40 million, 520.0% more than in 2024.

Analyst Summary

According to 14 analysts, the average rating for EVH stock is "Buy." The 12-month stock price target is $5.92, which is an increase of 20.76% from the latest price.

Price Target

$5.92

(20.76% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 14, 2026

Data Sources Report a data error